Approval of a new nucleoside. Component of complete once daily regimen
MMW Fortschritte der Medizin 146 Spec No 1: 91
2004
ISSN/ISBN: 1438-3276 PMID: 15373067 Document Number: 568864
Document emailed within 1 workday
Related Documents
Schilcher, R.B.; Haas, C.D.; Samson, M.K.; Young, J.D.; Baker, L.H. 1986: Phase i evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen Cancer Research 46(6): 3147-3151Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Flandre, P.; Descamps, D.; Joly, V.; Meiffrédy, V.; Tamalet, C.; Izopet, J.; Aboulker, J-Pierre.; Brun-Vézinet, Fçoise. 2003: Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received Antiviral Therapy 8(1): 65-72
Reynolds, W.J.; Shaar, S.F.; Buik, A.; Lancee, W.J. 1979: Oxaprozin: a once-daily treatment regimen in rheumatoid arthritis Journal of Rheumatology 6(3): 345-350
Pokaliueva, L.A.; Zorina, N.P.; Snigur, O.I.; Borovik, G.A. 1974: Level of physical development in children as dependent on the organization of the daily regimen Gigiena i Sanitariia 10: 110-111
Bradsher, R.W.; Snow, R.M. 1984: Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen American Journal of Medicine 77(4c): 63-67
Mankhatitham, W.; Lueangniyomkul, A.; Manosuthi, W. 2011: Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen Southeast Asian Journal of Tropical Medicine and Public Health 42(3): 651-658
Laczika, K.; Staudinger, T.; Hollenstein, U.; Presterl, E.; Locker, G.J.; Knapp, S.; Burgmann, H.; Stoiser, B.; Kofler, J.; Winter, W.; Graninger, W.; Frass, M. 1997: Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients Wiener Klinische Wochenschrift 109(21): 840-844
Shapiro, A.L. 1980: Hygienic evaluation of the daily regimen and work capacity dynamics in schoolchildren with health deviations Gigiena i Sanitariia 11: 33-35
Rademaker, M.; Corrie, J.; Lindsay, B.A.; Flapan, A.D.; Padfield, P.L. 1989: Low dose, twice daily captopril and frusemide: a safe, effective and flexible third line treatment regimen for hypertension Journal of Human Hypertension 3(3): 173-177
Furuta, T.; Sugimoto, M.; Kodaira, C.; Nishino, M.; Yamade, M.; Uotani, T.; Ikuma, M.; Shirai, N. 2010: The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd rescue regimen for eradication of H. pylori Hepato-Gastroenterology 57: 102-103
Manosuthi, W.; Sungkanuparph, S.; Ruxrungtham, K.; Prasithsirikul, W.; Athichathanabadi, C.; Tantisiriwat, W.; Bowonwatanuwong, C.; Chumpathat, N.; Chaovavanich, A. 2008: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir Journal of Acquired Immune Deficiency Syndromes 47(1): 127-129
Hauptmann, G.; Grosshans, E.; Heid, E. 1974: Lupus erythematosus syndrome and complete deficiency of the fourth component of complement Bollettino dell'Istituto Sieroterapico Milanese 53(1 Suppl): 228
Gausch, K. 1970: Central bearing bite-taking for complete dentures in daily practice Deutsche Zahnarztliche Zeitschrift 25(2): 225-230
Cieślak, J.; Sobkowski, M.; Jankowska, J.; Wenska, M.; Szymczak, M.; Imiolczyk, B.; Zagórowska, I.; Shugar, D.; Stawiński, J.; Kraszewski, A. 2001: Nucleoside phosphate analogues of biological interest, and their synthesis via aryl nucleoside H-phosphonates as intermediates Acta Biochimica Polonica 48(2): 429-442
Cass, C.E.; Dahlig, E.; Lau, E.Y.; Lynch, T.P.; Paterson, A.R. 1979: Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of Hela cells Cancer Research 39(4): 1245-1252
Baird-Gunning, E.; Ackermann, T.; Lim, J.K. 2019: Lumbar Incisional Hernia Repair: Complete Reconstruction of the Deficient Myofascial Component Using Christmas Tree Bone Anchors American Surgeon 85(3): 280-283
Hanke, C.W.; Swanson, N.; Bruce, S.; Berman, B.; Kulp, J.; Levy, S. 2011: Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream Journal of Drugs in Dermatology: Jdd 10(2): 165-170
Mcelhinney, R.S.; Mccormick, J.E.; Bibby, M.C.; Double, J.A.; Atassi, G.; Dumont, P.; Pratesi, G.; Radacic, M. 1989: Nucleoside analogues. 9. Seco-nucleoside analogues of some 5-fluorouracil/nitrosourea molecular combinations having uracil as base: synthesis and anti-tumour activity Anti-Cancer Drug Design 4(3): 191-207
Luque, A.E.; Cohn, S.E.; Park, J.-G.; Cramer, Y.; Weinberg, A.; Livingston, E.; Klingman, K.L.; Aweeka, F.; Watts, D.H. 2015: Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study Antimicrobial Agents and ChemoTherapy 59(4): 2094-2101